Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging
International Journal of Geriatric Psychiatry | Jun 09, 2018
Empagliflozin in women with type 2 diabetes and cardiovascular disease – An analysis of EMPA-REG OUTCOME
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jun 07, 2018
Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study
Journal of the American Academy of Dermatology | Jun 07, 2018
Most read this week